vs

Side-by-side financial comparison of FINANCIAL INSTITUTIONS INC (FISI) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

FINANCIAL INSTITUTIONS INC is the larger business by last-quarter revenue ($62.7M vs $41.8M, roughly 1.5× Neuronetics, Inc.). FINANCIAL INSTITUTIONS INC runs the higher net margin — 33.5% vs -17.2%, a 50.7% gap on every dollar of revenue. Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -2.0%).

The Mizuho Financial Group, Inc. , known from 2000 to 2003 as Mizuho Holdings and abbreviated as MHFG or simply Mizuho, is a Japanese banking holding company headquartered in the Ōtemachi district of Chiyoda, Tokyo, Japan. The group was formed in 2000–2002 by merger of Dai-Ichi Kangyo Bank, Fuji Bank, and Industrial Bank of Japan. The name mizuho (瑞穂) literally means "abundant rice" in Japanese and "harvest" in the figurative sense.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

FISI vs STIM — Head-to-Head

Bigger by revenue
FISI
FISI
1.5× larger
FISI
$62.7M
$41.8M
STIM
Higher net margin
FISI
FISI
50.7% more per $
FISI
33.5%
-17.2%
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-2.0%
FISI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FISI
FISI
STIM
STIM
Revenue
$62.7M
$41.8M
Net Profit
$21.0M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
33.5%
-17.2%
Revenue YoY
85.7%
Net Profit YoY
24.3%
43.2%
EPS (diluted)
$1.04
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FISI
FISI
STIM
STIM
Q1 26
$62.7M
Q4 25
$64.1M
$41.8M
Q3 25
$63.8M
$37.3M
Q2 25
$59.7M
$38.1M
Q1 25
$57.2M
$32.0M
Q4 24
$41.6M
$22.5M
Q3 24
$50.1M
$18.5M
Q2 24
$65.2M
$16.4M
Net Profit
FISI
FISI
STIM
STIM
Q1 26
$21.0M
Q4 25
$20.0M
$-7.2M
Q3 25
$20.5M
$-9.0M
Q2 25
$17.5M
$-10.1M
Q1 25
$16.9M
$-12.7M
Q4 24
$-82.8M
$-12.7M
Q3 24
$13.5M
$-13.3M
Q2 24
$25.6M
$-9.8M
Gross Margin
FISI
FISI
STIM
STIM
Q1 26
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Operating Margin
FISI
FISI
STIM
STIM
Q1 26
Q4 25
37.4%
-12.1%
Q3 25
39.5%
-19.6%
Q2 25
36.0%
-21.1%
Q1 25
36.0%
-34.4%
Q4 24
-276.9%
-51.0%
Q3 24
29.0%
-41.7%
Q2 24
46.2%
-51.7%
Net Margin
FISI
FISI
STIM
STIM
Q1 26
33.5%
Q4 25
38.3%
-17.2%
Q3 25
32.1%
-24.3%
Q2 25
29.3%
-26.6%
Q1 25
29.5%
-39.6%
Q4 24
-198.9%
-56.4%
Q3 24
26.9%
-72.0%
Q2 24
39.3%
-59.8%
EPS (diluted)
FISI
FISI
STIM
STIM
Q1 26
$1.04
Q4 25
$0.96
$-0.10
Q3 25
$0.99
$-0.13
Q2 25
$0.85
$-0.15
Q1 25
$0.81
$-0.21
Q4 24
$-5.32
$-0.34
Q3 24
$0.84
$-0.44
Q2 24
$1.62
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FISI
FISI
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$85.5M
$28.1M
Total DebtLower is stronger
$114.0M
$65.8M
Stockholders' EquityBook value
$22.4M
Total Assets
$6.3B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FISI
FISI
STIM
STIM
Q1 26
$85.5M
Q4 25
$108.8M
$28.1M
Q3 25
$185.9M
$28.0M
Q2 25
$93.0M
$11.0M
Q1 25
$167.4M
$20.2M
Q4 24
$87.3M
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Total Debt
FISI
FISI
STIM
STIM
Q1 26
$114.0M
Q4 25
$193.7M
$65.8M
Q3 25
$115.0M
$65.7M
Q2 25
$115.0M
$55.5M
Q1 25
$124.9M
$55.3M
Q4 24
$124.8M
$55.2M
Q3 24
$124.8M
$46.0M
Q2 24
$124.7M
$59.8M
Stockholders' Equity
FISI
FISI
STIM
STIM
Q1 26
Q4 25
$628.9M
$22.4M
Q3 25
$621.7M
$27.4M
Q2 25
$601.7M
$27.1M
Q1 25
$589.9M
$35.5M
Q4 24
$569.0M
$27.7M
Q3 24
$500.3M
$9.4M
Q2 24
$467.7M
$19.4M
Total Assets
FISI
FISI
STIM
STIM
Q1 26
$6.3B
Q4 25
$6.3B
$141.6M
Q3 25
$6.3B
$145.5M
Q2 25
$6.1B
$134.7M
Q1 25
$6.3B
$142.0M
Q4 24
$6.1B
$140.9M
Q3 24
$6.2B
Q2 24
$6.1B
$96.8M
Debt / Equity
FISI
FISI
STIM
STIM
Q1 26
Q4 25
0.31×
2.94×
Q3 25
0.18×
2.40×
Q2 25
0.19×
2.05×
Q1 25
0.21×
1.56×
Q4 24
0.22×
1.99×
Q3 24
0.25×
4.90×
Q2 24
0.27×
3.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FISI
FISI
STIM
STIM
Operating Cash FlowLast quarter
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FISI
FISI
STIM
STIM
Q1 26
Q4 25
$18.8M
$908.0K
Q3 25
$-6.9M
$-785.0K
Q2 25
$-5.7M
$-3.5M
Q1 25
$10.0M
$-17.0M
Q4 24
$77.1M
$-8.6M
Q3 24
$2.1M
$-5.4M
Q2 24
$35.7M
$-5.0M
Free Cash Flow
FISI
FISI
STIM
STIM
Q1 26
Q4 25
$13.3M
$692.0K
Q3 25
$-7.9M
$-899.0K
Q2 25
$-7.3M
$-3.8M
Q1 25
$9.2M
$-17.2M
Q4 24
$72.2M
$-8.7M
Q3 24
$-299.0K
$-5.8M
Q2 24
$34.7M
$-5.6M
FCF Margin
FISI
FISI
STIM
STIM
Q1 26
Q4 25
20.7%
1.7%
Q3 25
-12.4%
-2.4%
Q2 25
-12.3%
-9.9%
Q1 25
16.1%
-53.8%
Q4 24
173.3%
-38.6%
Q3 24
-0.6%
-31.3%
Q2 24
53.3%
-34.0%
Capex Intensity
FISI
FISI
STIM
STIM
Q1 26
Q4 25
8.7%
0.5%
Q3 25
1.6%
0.3%
Q2 25
2.7%
0.7%
Q1 25
1.4%
0.7%
Q4 24
11.9%
0.4%
Q3 24
4.9%
2.1%
Q2 24
1.5%
3.7%
Cash Conversion
FISI
FISI
STIM
STIM
Q1 26
Q4 25
0.94×
Q3 25
-0.34×
Q2 25
-0.33×
Q1 25
0.59×
Q4 24
Q3 24
0.16×
Q2 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FISI
FISI

Net Interest Income$52.0M83%
Noninterest Income$10.7M17%

STIM
STIM

Segment breakdown not available.

Related Comparisons